Compare EVO & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | GROY |
|---|---|---|
| Founded | 1993 | 2020 |
| Country | Germany | Canada |
| Employees | 4766 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 895.8M | 1.0B |
| IPO Year | N/A | 2020 |
| Metric | EVO | GROY |
|---|---|---|
| Price | $2.58 | $3.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $7.00 | $5.90 |
| AVG Volume (30 Days) | 107.5K | ★ 2.9M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $147.12 |
| Revenue Next Year | $7.13 | $51.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $1.23 |
| 52 Week High | $4.80 | $5.45 |
| Indicator | EVO | GROY |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 47.11 |
| Support Level | $2.32 | $3.39 |
| Resistance Level | $3.82 | $4.01 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 98.11 | 63.78 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.